17-18149553-T-C

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_016239.4(MYO15A):ā€‹c.7185T>Cā€‹(p.Phe2395=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.997 in 1,614,224 control chromosomes in the GnomAD database, including 802,041 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.99 ( 75405 hom., cov: 33)
Exomes š‘“: 1.0 ( 726636 hom. )

Consequence

MYO15A
NM_016239.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.603
Variant links:
Genes affected
MYO15A (HGNC:7594): (myosin XVA) This gene encodes an unconventional myosin. This protein differs from other myosins in that it has a long N-terminal extension preceding the conserved motor domain. Studies in mice suggest that this protein is necessary for actin organization in the hair cells of the cochlea. Mutations in this gene have been associated with profound, congenital, neurosensory, nonsyndromal deafness. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Read-through transcripts containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternatively spliced transcript variants have been described, but their full length sequences have not been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 17-18149553-T-C is Benign according to our data. Variant chr17-18149553-T-C is described in ClinVar as [Benign]. Clinvar id is 45758.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-18149553-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.603 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYO15ANM_016239.4 linkuse as main transcriptc.7185T>C p.Phe2395= synonymous_variant 35/66 ENST00000647165.2 NP_057323.3
MYO15AXM_017024715.3 linkuse as main transcriptc.7188T>C p.Phe2396= synonymous_variant 33/64 XP_016880204.1
MYO15AXM_017024714.3 linkuse as main transcriptc.7125T>C p.Phe2375= synonymous_variant 32/63 XP_016880203.1
LOC124903944XR_007065652.1 linkuse as main transcript downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYO15AENST00000647165.2 linkuse as main transcriptc.7185T>C p.Phe2395= synonymous_variant 35/66 NM_016239.4 ENSP00000495481 P1Q9UKN7-1
MYO15AENST00000578999.1 linkuse as main transcriptn.806T>C non_coding_transcript_exon_variant 4/45

Frequencies

GnomAD3 genomes
AF:
0.995
AC:
151427
AN:
152238
Hom.:
75341
Cov.:
33
show subpopulations
Gnomad AFR
AF:
1.00
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.950
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.984
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.998
GnomAD3 exomes
AF:
0.986
AC:
246159
AN:
249576
Hom.:
121527
AF XY:
0.990
AC XY:
134005
AN XY:
135402
show subpopulations
Gnomad AFR exome
AF:
1.00
Gnomad AMR exome
AF:
0.904
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad SAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.991
GnomAD4 exome
AF:
0.997
AC:
1457389
AN:
1461868
Hom.:
726636
Cov.:
69
AF XY:
0.997
AC XY:
725343
AN XY:
727236
show subpopulations
Gnomad4 AFR exome
AF:
1.00
Gnomad4 AMR exome
AF:
0.911
Gnomad4 ASJ exome
AF:
1.00
Gnomad4 EAS exome
AF:
0.999
Gnomad4 SAS exome
AF:
1.00
Gnomad4 FIN exome
AF:
1.00
Gnomad4 NFE exome
AF:
1.00
Gnomad4 OTH exome
AF:
0.998
GnomAD4 genome
AF:
0.995
AC:
151550
AN:
152356
Hom.:
75405
Cov.:
33
AF XY:
0.994
AC XY:
74029
AN XY:
74504
show subpopulations
Gnomad4 AFR
AF:
1.00
Gnomad4 AMR
AF:
0.951
Gnomad4 ASJ
AF:
1.00
Gnomad4 EAS
AF:
1.00
Gnomad4 SAS
AF:
1.00
Gnomad4 FIN
AF:
1.00
Gnomad4 NFE
AF:
1.00
Gnomad4 OTH
AF:
0.998
Alfa
AF:
0.999
Hom.:
37335
Bravo
AF:
0.990
Asia WGS
AF:
0.998
AC:
3470
AN:
3478
EpiCase
AF:
1.00
EpiControl
AF:
1.00

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingGeneDxMay 09, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 29, 2012This is the major allele (dbSNP rs2955379). -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Autosomal recessive nonsyndromic hearing loss 3 Benign:3
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabSep 05, 2021- -
Benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 21, 2021- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
4.0
DANN
Benign
0.78

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2955379; hg19: chr17-18052867; COSMIC: COSV52761979; COSMIC: COSV52761979; API